Showing results (1481-1490 of 1,593) with videos related to

Sort By:
Pageof 160
NPJ Science of Food|November 23, 2019
Food authentication from shotgun sequencing reads with an application on high protein powdersNiina Haiminen, Stefan Edlund, David Chambliss, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseMatthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Pain|June 28, 2019
Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1Rajesh Khanna, Aubin Moutal, Katherine A White, et al.
International Journal of Molecular Sciences|April 17, 2025
Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical CarcinomaInken Flörkemeier, Hannah L Hotze, Anna Lena Heyne, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2021
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIIIJenny Chia, Sabine Pestel, Isabelle Glauser, et al.
The Journal of Clinical Investigation|November 2, 2013
Insulin receptor substrate signaling suppresses neonatal autophagy in the heartChristian Riehle, Adam R Wende, Sandra Sena, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of AβOskar Adolfsson, Maria Pihlgren, Nicolas Toni, et al.
American Journal of Physiology. Renal Physiology|June 13, 2024
Diffusion tensor MRI is sensitive to fibrotic injury in a mouse model of oxalate-induced chronic kidney diseaseRohan S Virgincar, Aaron K Wong, Kai H Barck, et al.
Nature Chemical Biology|October 1, 2013
Role of sirtuins in lifespan regulation is linked to methylation of nicotinamideKathrin Schmeisser, Johannes Mansfeld, Doreen Kuhlow, et al.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
Pageof 160